13 unknown. 13 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 13 | Unknown 13 |
| Phase 1 | 4 | Unknown 4 |
Follow Liposarcoma: new trials by email Literature Review of Liposarcoma trials Research Report on Liposarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) Seclidemstat - Ewing Sarcoma, Myxoid Liposarcoma | Phase 1 / Phase 2 | Unknown | Salarius Pharmaceuticals, LLC | 10 | 2022-01-15 | 2023-08-01 |
| A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents OR2805, Cemiplimab, Docetaxel - Cancer, Tumor, Solid | Phase 1 / Phase 2 | Unknown | OncoResponse, Inc. | 172 | 2021-09-09 | 2023-11-02 |
| Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas Hypofractionated radiotherapy, Hyperthermia - Sarcoma, Alveolar Soft Part Sarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 30 | 2018-06-01 | 2021-02-01 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 46 | 2017-02-11 | 2021-01-22 |
| A Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma Ribociclib - Liposarcomas, Dedifferentiated, Liposarcoma - Well Differentiated | Phase 2 | Unknown | Assaf-Harofeh Medical Center | 30 | 2016-07-01 | 2017-10-25 |
| A Phase II Study Assessing Efficacy & Safety of Ribociclib in Patients With Advanced Well/Dedifferentiated Liposarcoma ribociclib - Liposarcoma, Soft Tissue Sarcoma | Phase 2 | Unknown | Hadassah Medical Organization | 30 | 2016-05-01 | 2016-11-23 |
| Hypofractionated Radiotherapy in Locally Advanced Myxoid Liposarcomas of Extremities or Trunk Wall (LIPO-MYX Trial) Hypofractionated radiotherapy - Myxoid Liposarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 35 | 2015-04-24 | 2019-06-17 |
| Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma Autologous dendritic cell vaccine - Sarcoma, Neoplasms, Connective and Soft Tissue | Phase 1 / Phase 2 | Unknown | N.N. Petrov National Medical Research Center of Oncology | 48 | 2013-06-01 | 2019-11-20 |
| Trial of Nilotinib and Adriamycin as Treatment in Liposarcomas and Leiomyosarcomas of Retroperitoneum Nilotinib-adriamycin - Retroperitoneal Liposarcoma, Retroperitoneal Leiomyosarcoma | Phase 1 / Phase 2 | Unknown | Broto, Javier Martín, M.D. | 40 | 2012-01-01 | 2015-10-27 |
| Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcomas dose reduction of preoperative radiotherapy in MLS - Myxoid Liposarcoma of Soft Tissue | Phase 2 | Unknown | The Netherlands Cancer Institute | 80 | 2010-12-15 | 2021-08-04 |
| Brostallicin Clinical Trial for Myxoid Liposarcoma Brostallicin - Myxoid Liposarcoma | Phase 2 | Unknown | Systems Medicine LLC | 24 | 2007-08-01 | 2010-02-26 |
| Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma brostallicin, doxorubicin hydrochloride - Ovarian Cancer, Sarcoma | Phase 2 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 118 | 2006-10-01 | 2014-08-08 |
| Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma temozolomide - Endometrial Cancer, Ovarian Cancer | Phase 2 | Unknown | Herbert Irving Comprehensive Cancer Center | 25 | 1998-09-01 | 2014-01-06 |
Sarcoma (10) · Leiomyosarcoma (7) · Liposarcoma, Myxoid (7) · Fibrosarcoma (5) · Histiocytoma, Malignant Fibrous (5) · Neurofibrosarcoma (5) · Sarcoma, Synovial (5) · Sarcoma, Alveolar Soft Part (4) · Rhabdomyosarcoma (3) · Chondrosarcoma (2) · Chondrosarcoma, Extraskeletal Myxoid (2) · Hemangiosarcoma (2) · Malignant mesenchymal tumor (2) · Myosarcoma (2)
Neoplasms by Histologic Type (13) · Neoplasms, Adipose Tissue (13) · Neoplasms (12) · Neoplasms, Connective and Soft Tissue (12) · Neoplasms, Connective Tissue (7) · Neoplasms, Muscle Tissue (7) · Neoplasms, Nerve Tissue (6) · Neoplasms, Fibrous Tissue (5) · Nerve Sheath Neoplasms (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neurofibroma (5) · Neuromuscular Diseases (5) · Peripheral Nervous System Diseases (5) · Peripheral Nervous System Neoplasms (5)
Radiation Dose Hypofractionation (3) · Doxorubicin (2) · brostallicin (2) · ribociclib (2) · Cyclophosphamide (1) · Diathermy (1) · Docetaxel (1) · Temozolomide (1) · Topotecan (1) · cemiplimab (1) · cytochrome C synthetase (1) · lentiviral minigene vaccine of COVID-19 coronavirus (1) · nilotinib (1) · seclidemstat (1)
Maria Sklodowska-Curie National Research Institute of Oncology (3) · Assaf-Harofeh Medical Center (1) · Broto, Javier Martín, M.D. (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Hadassah Medical Organization (1) · Herbert Irving Comprehensive Cancer Center (1) · N.N. Petrov National Medical Research Center of Oncology (1) · OncoResponse, Inc. (1) · Salarius Pharmaceuticals, LLC (1) · Systems Medicine LLC (1) · The Netherlands Cancer Institute (1)
United States (5) · Poland (3) · Israel (2) · Netherlands (2) · Denmark (1) · Norway (1) · Russia (1) · Spain (1) · United Kingdom (1)
Daniela Katz, M.D (1) · Daniela Katz, MD (1) · Hans Gelderblom, MD, PhD (1) · Jack Singer, M.D. (1) · Rick Haas, MD,PhD (1) · Robert N. Taub, MD, PhD (1) · Yuriy Komarov, PhD (1)